Global - Impulse Dynamics
  • Home
  • Patients
  • Providers
    • CE Mark Indications & Patient Selection
    • Procedure and Mode of Action
    • Publications
    • Instructions for Use and Product Manuals
  • Company
    • News
    • Board of Directors
    • Executive Team
    • Governance
    • Resources
    • Careers
    • Contact Us
  • Events
  • Find A Doctor
  • REGION
    • US
    • DE
    • IT
    • Global
Select Page

Impulse Dynamics Announces FDA Approval for Magnetic Resonance Imaging

by Impulse Dynamics | Jan 20, 2021 | News and Events, Press Releases

NEWS IMPULSE DYNAMICS ANNOUNCES FDA APPROVAL FOR MAGNETICRESONANCE IMAGING FDA Clears Potential Hurdle for Many Heart Failure Patients MARLTON, N.J., January 20, 2021 — Impulse Dynamics, a company dedicated to improving the lives of people with heart failure (HF),...

Impulse Dynamics Closes $60 Million Financing

by Impulse Dynamics | Jan 12, 2021 | News and Events, Press Releases

NEWS IMPULSE DYNAMICS CLOSES $60 MILLION FINANCING Funding to Accelerate Clinical and Product Development Pipelines, Commercialization of Optimizer Smart System for Heart Failure MARLTON, N.J., January 12, 2021 — Impulse Dynamics, a company dedicated to helping...

Impulse Dynamics Announces First Heart Failure Patient Treated with CCM Therapy in Brazil

by Impulse Dynamics | Jan 5, 2021 | News and Events, Press Releases

NEWS Impulse Dynamics Announces First Heart Failure Patient Treated with CCM Therapy in Brazil Breakthrough Therapy Now Commercially Available in South America’s Most Populous Country MARLTON, N.J. – January 05, 2021 – Impulse Dynamics, a company dedicated to helping...

Recent Posts

  • Impulse Dynamics Receives Approval to Sell Optimizer CCM Devices in China
  • Global Regulatory Organization Certifies Optimizer Smart Device as Compliant for Whole-Body MRI Scans in the EU
  • Impulse Dynamics Announces FDA Approval for Magnetic Resonance Imaging
  • Impulse Dynamics Closes $60 Million Financing
  • Impulse Dynamics Announces First Heart Failure Patient Treated with CCM Therapy in Brazil

Recent Comments

  • 3twofold on The FIX-HF-16 clinical study to be supported by the Ludwigshafen research institute

Archives

  • February 2021
  • January 2021
  • April 2020
  • March 2020
  • December 2019
  • November 2019
  • October 2019
  • August 2019
  • March 2019
  • May 2018
  • December 2017
  • August 2017
  • May 2017
  • March 2017
  • September 2016
  • May 2016
  • March 2016
  • January 2016
  • November 2015
  • August 2015
  • July 2015
  • January 2015
  • December 2014

Categories

  • News and Events
  • Press Releases

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Like most websites on the internet, this website uses cookies. By using our website, you agree to our Cookie Policy. I Accept